FLC > 800 mg/L at diagnosis is also linked to severe renal failure regardless of M-protein type, and quickly lowering FLC with antimyeloma therapies is associated with significant improvements in renal function [34]. This evidence concerns the gene MYOM2 and acute kidney injury.